DexCom valuation
Valuation
The P/E ratio is 32.8. The average price target of 26 analysts is $98.58.
Data as of November 16, 2026
DexCom compared with similar companies
DexCom's P/E (trailing 12 months): 32.8, +14% against the median of a group of 10 similar companies (28.7).
| Metric | DexCom | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 32.8 | 28.7 | 25.0 – 32.9 | Middle |
| Forward P/E | 26.6 | 19.1 | 15.3 – 25.2 | High |
| EV/EBITDA | 20.5 | 16.1 | 13.9 – 19.7 | High |
| Price/book | 12.3 | 5.03 | 2.93 – 7.34 | High |
| Price/sales | 6.09 | 4.16 | 3.18 – 7.10 | Middle |
| Gross margin | 63.4% | 68.0% | 64.3% – 70.6% | Low |
| Operating margin | 24.0% | 19.2% | 15.2% – 22.0% | High |
| Net margin | 19.4% | 13.4% | 10.0% – 14.6% | High |
| ROE | 37.7% | 11.6% | 10.0% – 18.0% | High |
| Debt/equity | 0.55 | 0.55 | 0.21 – 0.63 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
DexCom: valuation over time
On the latest fiscal year's earnings (2025), DexCom's P/E today is 39.3, below the median of its last 6 fiscal years (82.5; between 31.8 and 253.3 from 2020 to 2025). Relative to earnings, the stock costs less than it used to.
| Fiscal year | Price at year end | Earnings per share | P/E |
|---|---|---|---|
| 2025 | $66.37 | $2.09 | 31.8 |
| 2024 | $77.77 | $1.42 | 54.8 |
| 2023 | $124.09 | $1.30 | 95.5 |
| 2022 | $113.24 | $0.82 | 138.1 |
| 2021 | $134.24 | $0.53 | 253.3 |
| 2020 | $92.43 | $1.33 | 69.5 |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $31.08B
- Enterprise value
- $30.65B
- PEG
- 1.31
- EV/revenue
- 6.01
Profitability and growth
- ROA
- 11.1%
- ROIC
- 15.5%
- Revenue growth (year over year)
- 11.2%
- Earnings growth (year over year)
- 2.6%
Financial health
- Total cash
- $1.82B
- Total debt
- $1.39B
- Current ratio
- 1.74
- Quick ratio
- 1.34
- Altman Z-Score
- 6.93
- Piotroski F-Score
- 7.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $98.58
- Median price target
- $96.50
- High price target
- $120.00
- Low price target
- $79.00
- Analysts with a price target
- 26
- Consensus
- Strong buy
- Forward EPS
- $3.13
- EPS estimate, current year
- $2.70
Shares and trading
- Beta
- 1.44
- Average volume
- 4.23M
- Shares outstanding
- 372.95M
- Float
- 371.59M
- Institutional ownership
- 108.0%
- Insider ownership
- 0.8%
- Short interest (% of float)
- 4.9%
- Short ratio (days)
- 3.52
